• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy
    Subscribe to $TTNP

    Titan Pharmaceuticals Inc.

    Subscribe to $TTNP
    $TTNP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform that focuses primarily on the treatment for chronic diseases. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program, TP-2021 for use in combination with ProNeura technology for treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including non-clinical evaluation of the ProNeura platform in malaria prophylaxis. Titan Pharmaceuticals, Inc. was incorporated in 1992 and is based in South San Francisco, California.

    IPO Year:

    Exchange: NASDAQ

    Website: titanpharm.com

    Peers

    $AERI
    $CTXR
    $SPPI
    $TMDI

    Recent Analyst Ratings for Titan Pharmaceuticals Inc.

    DatePrice TargetRatingAnalyst
    See more ratings

    Titan Pharmaceuticals Inc. SEC Filings

    See more
    • Titan Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

      8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      6/27/25 4:15:19 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Titan Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      6/18/25 4:49:02 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 425 filed by Titan Pharmaceuticals Inc.

      425 - TITAN PHARMACEUTICALS INC (0000910267) (Subject)

      6/3/25 5:25:48 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Titan Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      6/3/25 5:25:13 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Titan Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      6/2/25 5:20:12 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form 10-Q filed by Titan Pharmaceuticals Inc.

      10-Q - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      5/14/25 4:05:26 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form DEFA14A filed by Titan Pharmaceuticals Inc.

      DEFA14A - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      5/2/25 4:11:23 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form DEF 14A filed by Titan Pharmaceuticals Inc.

      DEF 14A - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      5/2/25 4:05:25 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Titan Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      4/22/25 4:45:43 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form PRE 14A filed by Titan Pharmaceuticals Inc.

      PRE 14A - TITAN PHARMACEUTICALS INC (0000910267) (Filer)

      4/22/25 4:30:57 PM ET
      $TTNP
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care